BRD-K85925969-001-16-6 (Substance)

Compound:

Zalcitabine

Synonyms:BRD-K85925969-001-16-6

Id:340081134

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View BRD-K85925969-001-16-6's neighborhood in the knowledge graph.

Submit

Results found

Linked to

	Label	Description
	L1000 LINCS DCIC 2021 LIVB002 HUH7 72H C12 zalcitabine 15uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.B020 MDAMB231 24H E18 zalcitabine 0.01uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.B020 MDAMB231 24H E14 zalcitabine 0.74uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC REP.A020 HA1E 24H E17 zalcitabine 0.12um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC 2021 REP.B020 A549 24H E17 zalcitabine 0.03uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.A020 HELA 24H E15 zalcitabine 1.11uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.B020 THP1 24H E17 zalcitabine 0.03uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC REP.A020 HELA 24H E18 zalcitabine 0.04um Biosample (Entity type)	A biosample from LINCS produced as part of the L1000 Phase2 project
	L1000 LINCS DCIC 2021 REP.A020 MDAMB231 24H E17 zalcitabine 0.125uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project
	L1000 LINCS DCIC 2021 REP.A020 PC3 24H E18 zalcitabine 0.04uM Biosample (Entity type)	A biosample from LINCS produced as part of the LINCS 2021 project